Metastatic Urothelial Cancer Unknown Status Phase 2 Trials for Sapanisertib (DB11836)

IndicationStatusPhase
DBCOND0066157 (Metastatic Urothelial Cancer)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03745911Paclitaxel and TAK-228 in Urothelial CarcinomaTreatment